papaverine and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide

papaverine has been researched along with seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, SC1

Other Studies

1 other study(ies) available for papaverine and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide

ArticleYear
Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter.
    Regulatory peptides, 2007, Jul-05, Volume: 142, Issue:1-2

    Topics: Animals; Dose-Response Relationship, Drug; Esophageal Sphincter, Lower; Guinea Pigs; In Vitro Techniques; Male; Muscle Relaxation; Oligopeptides; Papaverine; Receptor, PAR-1; Receptor, PAR-2; Receptors, Proteinase-Activated; Thrombin; Trypsin

2007